Lack of pharmacokinetic interaction between anidulafungin and tacrolimus. - Wikidata - wikimedia - TriplyDB

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

http://www.wikidata.org/entity/Q42612968

about

Limited-sampling strategies for anidulafungin in critically ill patients.Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.Population pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections.Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.Does Weight Impact Anidulafungin Pharmacokinetics?Pharmacology and antifungal properties of anidulafungin, a new echinocandin.Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.Echinocandin antifungal drugs in fungal infections: a comparison.Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?Safety and interactions of new antifungals in stem cell transplant recipients.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Impact of special patient populations on the pharmacokinetics of echinocandins.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.Quantitation of azoles and echinocandins in compartments of peripheral blood by liquid chromatography-tandem mass spectrometry Interactions between anti-infective agents and immunosuppressants in solid organ transplantation.Anidulafungin and its role in candida infections In vitro and in vivo studies to characterize the clearance mechanism and potential cytochrome P450 interactions of anidulafungin.Antifungal management practices in liver transplant recipients.Safety of anidulafungin in solid organ transplant recipients

P2860

Q35105939-D3EC5EE4-3222-4E14-AA54-9920FAF313D2 Q35959489-7E8EBFCD-6D46-4AFB-B9CD-15786F3A0886 Q36390234-1E6E499A-4B00-4F41-9585-3DC84CD12470 Q36505401-2F1C8186-0A12-4B93-BC79-AFF6F0B902CA Q36757660-4A2A80B4-93BF-4D1C-BB8A-D92DE17F3E1E Q36864810-56F3695E-F0EF-4BD5-9D78-3F5AB52BECAB Q37253669-7AAAAC36-2A08-40E2-BDC8-03D9B3519772 Q37359613-3C5F7D12-6181-47E9-A7EA-CCB6ADF6E8BD Q37785979-6CACDD17-BC0F-4047-8761-FD60A7386050 Q37822777-C7D379A7-DC81-401C-9CFC-80B4D6A390D6 Q37854724-3FF5D8AF-853D-42D3-A56E-A526A71F7F43 Q38036740-930C0BDA-E3A1-443E-83B2-6C9AFEC661AC Q38284468-B5B76AE8-B068-4C49-9AFC-89DB33F4C0EA Q38462784-4AB46061-1139-46A9-9FD2-B16BA9BE4D03 Q38681635-69987737-03A0-4DAA-A0A6-06B1BAB93425 Q39020129-868B9161-BF94-46E2-981E-2A246ABEC764 Q40337647-BD95D9AF-A59E-4CFC-943C-BD259A86BDAD Q42272268-70139DB5-1DCF-4DA5-89D3-2343CD9882C7 Q42731827-3DC3394F-0B36-4331-8EA3-97192DF8462E Q43169846-758E98F3-2927-462D-B7DF-CAA5F3330001 Q46812014-CF214254-DDF8-4F77-82EB-85646EFA2654 Q57569012-191BEF21-2979-4067-BAD3-EF899277DF39

P2860

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

http://www.wikidata.org/entity/Q42612968

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

@en

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

@nl

type

label

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

@en

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

@nl

prefLabel

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

@en

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

@nl

P1433

Q42612968-C1EB01FA-9F38-4D01-817D-9B8514764A85

P1476

Q42612968-B3E0C279-BCC5-4E6C-B4B4-E68C325B284F

P2093

Q42612968-977A1DE6-FADA-4E90-8B64-5C920DA03CB6

Q42612968-9A059651-18DD-4D18-9AFB-74145FD47687

Q42612968-A875081B-40C4-4141-8A9A-45249B9DFE79

Q42612968-C9AB2698-F890-49D4-929B-1705F901D1CF

Q42612968-E7C0763C-B1E6-4D5E-9B55-E874D7C40CDA

P2860

Q42612968-002F1017-0C78-427C-9BDB-0157A900F230

Q42612968-2E21CBB2-1B87-4368-B0FC-C1C862D08D2E

Q42612968-3013673B-9409-42D0-944B-4B5CF0F884F1

Q42612968-33449875-741B-40E6-BB78-84ABF9031244

Q42612968-3B468EDE-5647-44CB-99F7-5824FD57821A

Q42612968-41DE2D8A-7BF4-43F2-B3C8-F6F332D638C6

Q42612968-475C64A8-8E61-4038-8FB8-E660101D65A0

Q42612968-4A341DEF-3C20-45CE-BE36-1B243B703F15

Q42612968-4B2C39E7-D68A-4EBC-9BE9-8EF718DDFDE1

Q42612968-4D4ADE0B-DAE3-4DD7-95E5-945B88A6BEFD

P304

Q42612968-9FEF8A84-6B78-48E5-B8D2-7E8E51EE09C4

P31

Q42612968-4910DF24-F9D4-476A-A44E-1175578CB90A

P356

Q42612968-DA257BDB-BA53-4FBC-AA4A-602FB375C75E

P433

Q42612968-DD8E771A-83EA-43D8-AD8B-0A105F742733

P478

Q42612968-6633AE15-42A6-4B76-8847-98139F38E54D

P577

Q42612968-66E0E167-1FB0-4464-A304-B7635E051954

P698

Q42612968-E9C0BEF1-AC0D-4340-84C8-2CC549D6DE63

P356

0091270006296764

P1433

The Journal of Clinical Pharmacology

P1476

Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.

@en

P2093

Bharat Damle

http://www.w3.org/2001/XMLSchema#string

David Krause

http://www.w3.org/2001/XMLSchema#string

James A Dowell

http://www.w3.org/2001/XMLSchema#string

Martin Stogniew

http://www.w3.org/2001/XMLSchema#string

Timothy Henkel

http://www.w3.org/2001/XMLSchema#string

P2860

Echinocandins and pneumocandins--a new antifungal class with a novel mode of action

Echinocandin antifungal drugs

Pharmacokinetics/pharmacodynamics of echinocandins.

Safety and tolerability of caspofungin acetate in the treatment of fungal infections.

Drug interactions with tacrolimus.

Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients.

Clinical pharmacokinetics of tacrolimus.

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.

P304

305-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270006296764

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17322142

http://www.w3.org/2001/XMLSchema#string